Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Cognitive problems may be present before chemotherapy in women with breast cancer

Share :

SABCS 2012

2 Dec 2011
Published: 12 Dec 2012
Views: 3238
Rating:
Save
Prof Bernadine Cimprich - University of Michigan School of Nursing, Ann Arbor, USA

At a press conference at SABCS 2012, Prof Cimprich presents data on a study looking at women undergoing chemotherapy who experience cognitive problems, commonly referred to as “chemo brain,” displayed alterations in neurocognitive responses prior to undergoing treatment.

Related Videos

Trastuzumab deruxtecan significantly improves PFS In breast cancer patients...
Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy
Trastuzumab deruxtecan significantly improves PFS In breast cancer patients previously treated with endocrine therapy ( Prof Giuseppe Curigliano - European Institute of Oncology, Milan, Italy )
13 Jun 2024
Nine-weeks trastuzumab still effective compared with one year trastuzumab for...
Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy
Nine-weeks trastuzumab still effective compared with one year trastuzumab for early-stage HER2 positive breast cancer ( Prof Pierfranco Conte - Istituto Oncologico Veneto, Padova, Italy )
3 Jun 2023
Assessment of QoL results and correlation with survival outcomes in phase III...
Dr Alberto Servetto - University of Naples Federico II, Naples, Italy
Assessment of QoL results and correlation with survival outcomes in phase III clinical trials in metastatic NSCLC ( Dr Alberto Servetto - University of Naples Federico II, Naples, Italy )
5 Apr 2023
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+...
Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )
28 Mar 2023
The advancements in radiotherapy for breast cancer patients
Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia
The advancements in radiotherapy for breast cancer patients ( Prof Ahlam Dohal - King Fahd Specialised Hospital Dammam, Dammam, Saudi Arabia )
1 Feb 2023
Loco-regional management after neoadjuvant chemotherapy
Prof Terry Mamounas - Orlando Health Cancer Institute, Orlando, USA
Loco-regional management after neoadjuvant chemotherapy ( Prof Terry Mamounas - Orlando Health Cancer Institute, Orlando, USA )
1 Feb 2023
Cancer pain management
Prof Ebtesam Ahmed - St John's University New York, New York City, USA
Cancer pain management ( Prof Ebtesam Ahmed - St John's University New York, New York City, USA )
1 Feb 2023
Management of HER2 positive metastatic breast cancer treatment algorithm
Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA
Management of HER2 positive metastatic breast cancer treatment algorithm ( Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA )
31 Jan 2023
Post neoadjuvant management in BRCA mutant breast cancer patients
Prof Banu Arun - MD Anderson Cancer Center, Houston, USA
Post neoadjuvant management in BRCA mutant breast cancer patients ( Prof Banu Arun - MD Anderson Cancer Center, Houston, USA )
31 Jan 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation